The Anti-VEGF Epidemic: What are the Implications for Glaucoma Services?

The early reports on intraocular bevacizumab injections talked about a transient predictable probably volume-related rise in intraocular pressure (IOP). As the usage of the drug increased across the globe, sustained IOP elevation was noted. This article provides an insightly into the causes of IOP s...

Descripción completa

Detalles Bibliográficos
Autores principales: Skalicky, Simon E, Clement, Colin I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2012
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161767/
https://www.ncbi.nlm.nih.gov/pubmed/28028346
http://dx.doi.org/10.5005/jp-journals-10008-1106
_version_ 1782482107483815936
author Skalicky, Simon E
Clement, Colin I
author_facet Skalicky, Simon E
Clement, Colin I
author_sort Skalicky, Simon E
collection PubMed
description The early reports on intraocular bevacizumab injections talked about a transient predictable probably volume-related rise in intraocular pressure (IOP). As the usage of the drug increased across the globe, sustained IOP elevation was noted. This article provides an insightly into the causes of IOP spikes and its impact on glaucoma practice. HOW TO CITE THIS ARTICLE: Skalicky SE, I Clement C. The Anti-VEGF Epidemic: What are the Implications for Glaucoma Services? J Current Glau Prac 2012;6(2):55-57.
format Online
Article
Text
id pubmed-5161767
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-51617672016-12-27 The Anti-VEGF Epidemic: What are the Implications for Glaucoma Services? Skalicky, Simon E Clement, Colin I J Curr Glaucoma Pract Perspective The early reports on intraocular bevacizumab injections talked about a transient predictable probably volume-related rise in intraocular pressure (IOP). As the usage of the drug increased across the globe, sustained IOP elevation was noted. This article provides an insightly into the causes of IOP spikes and its impact on glaucoma practice. HOW TO CITE THIS ARTICLE: Skalicky SE, I Clement C. The Anti-VEGF Epidemic: What are the Implications for Glaucoma Services? J Current Glau Prac 2012;6(2):55-57. Jaypee Brothers Medical Publishers 2012 2012-08-16 /pmc/articles/PMC5161767/ /pubmed/28028346 http://dx.doi.org/10.5005/jp-journals-10008-1106 Text en Copyright © 2012; Jaypee Brothers Medical Publishers (P) Ltd. This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/
spellingShingle Perspective
Skalicky, Simon E
Clement, Colin I
The Anti-VEGF Epidemic: What are the Implications for Glaucoma Services?
title The Anti-VEGF Epidemic: What are the Implications for Glaucoma Services?
title_full The Anti-VEGF Epidemic: What are the Implications for Glaucoma Services?
title_fullStr The Anti-VEGF Epidemic: What are the Implications for Glaucoma Services?
title_full_unstemmed The Anti-VEGF Epidemic: What are the Implications for Glaucoma Services?
title_short The Anti-VEGF Epidemic: What are the Implications for Glaucoma Services?
title_sort anti-vegf epidemic: what are the implications for glaucoma services?
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161767/
https://www.ncbi.nlm.nih.gov/pubmed/28028346
http://dx.doi.org/10.5005/jp-journals-10008-1106
work_keys_str_mv AT skalickysimone theantivegfepidemicwhataretheimplicationsforglaucomaservices
AT clementcolini theantivegfepidemicwhataretheimplicationsforglaucomaservices
AT skalickysimone antivegfepidemicwhataretheimplicationsforglaucomaservices
AT clementcolini antivegfepidemicwhataretheimplicationsforglaucomaservices

Ejemplares similares